????????? ???????. D10.6
Conditions
Interventions
intranasal corticosteroid(Fluticasone),100 milligrams at night is administered for all 45 cases and after 8 week course of treatment, symptoms of adenoid hypertrophy will be evaluated.
Treatment - Drugs
intranasal corticosteroid(Fluticasone),100 milligrams at night is administered for all 45 cases and after 8 week course of treatment, symptoms of adenoid hypertrophy will be evaluated
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 14 Years
Inclusion criteria
Inclusion criteria: inclusion:children between 2-14 with hypertrophic adenoid exclusion:corticostreoid therapy more than 1 month;children with anatomical defects in head and neck
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adenoid size. Timepoint: before and after 8 week of corticosteroid therapy. Method of measurement: clinical symptoms such as snoring ...and adenoid size. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical manifestation and neck radiography. Timepoint: before and 8 weeks after corticostreoidtherapy. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahnaz Sadeghi Shabestari
Medical Faculty
Outcome results
None listed